marijuana stock news

 

Form 8-K for VAPOR CORP.


23-Apr-2015

Change in Directors or Principal Officers

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.On April 17, 2015, Robert Swayman resigned as a director of Vapor Corp. (the “Company”) as a result of his ceasing to be independent. Mr. Swayman is now providing business operations consulting services to the Company. Mr. Swayman’s decision to resign was not due to any disagreement with the Company relating to the Company’s operations, policies or practices.

On April 18, 2015, the Company appointed Mr. Daniel MacLachlan as a director replacing Mr. Swayman. Mr. MacLachlan served as the Chief Financial Officer of The Best One, Inc., from October 2014 through early February 2015, facilitating its merger with Tiger Media, Inc. (NYSE MKT: IDI). Mr. MacLachlan served as Director of Finance and Chief Financial Officer for TransUnion Risk and Alternative Data Solutions, Inc., after it acquired substantially all the assets of TLO, LLC (“TLO”), a leading provider of data fusion technology-driven investigative products and solutions, in December 2013. Mr. MacLachlan was Chief Financial Officer of TLO since its inception in 2009. Mr. MacLachlan was also appointed to the Audit Committee, the Compensation Committee and the Corporate Governance and Nominating Committee of the Company as an independent director in conformity with the Nasdaq Stock Market Rules.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Player’s Network, Inc. (PNTV) Forms GLFI, Inc as the Vehicle to Finance the Development of Non-US Cannabis Assets

PNTV Forms GLFI, Inc as the Vehicle to Finance the Development of…

GW Pharmaceuticals plc (GWPH) Completes Rolling New Drug Application Submission to U.S. Food and Drug Administration

GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Completes Rolling New Drug…

TILT Holdings Inc. (TLLTF) Subsidiary Jupiter Research Receives ISO 13485:2016 Medical Device Certification

TILT Holdings Subsidiary Jupiter Research Receives ISO 13485:2016 Medical Device Certification TILT…

Cronos Group Inc. (CRON) Announces Expanded Leadership Structure to Drive Next Phase of Growth

Cronos Group Announces Expanded Leadership Structure to Drive Next Phase of Growth…